THYROID FOLLICULAR CELL CARCINOGENESIS: MECHANISTIC AND SCIENCE POLICY CONSIDERATIONS (SAB REVIEW DRAFT)
Notice - This site contains archived material(s)
Archive disclaimer
Archive
disclaimer
Archived files are provided for reference
purposes only. These files are no longer maintained by the Agency and may be outdated. For
current EPA information, go to www.epa.gov. It is EPA's policy to
support reasonable accommodation to persons with disabilities, pursuant to the Rehabilitation
Act of 1973, 29 U.S.C. 791. If you need assistance with accessing archived files, contact
EPA's Reasonable Accommodations
or submit a request using the Contact Us form.
Abstract
A Technical Panel of EPA's Risk Assessment Forum investigated the potential mechanisms of action of agents that cause thyroid follicular tumors in animals and potentially in humans in an effort to develop a scientifically plausible approach for assessing risk due to exposure to these agents. Based on its review of relevant scientific information, the Technical Panel concluded that:
(1) thyroid follicular cell tumors may arise from long-term disturbances in thyroid-pituitary hormonal feedback under conditions of reduced circulating thyroid hormone and elevated thyroid stimulating hormone (TSH);
(2) the steps leading to these tumors are expected to show thresholds, such that the risks of tumor development are minimal when thyroid-pituitary homeostasis exists; and
(3) models that assume thresholds may be used to assess the risks of certain thyroid follicular cell tumors where there is evidence of thyroid-pituitary imbalance.
The policy set out in this report provides guidance on determining whether it is reasonable to presume that the observed thyroid follicular tumors are the result of thyroid-pituitary imbalance, and on selecting appropriate procedures to use in estimating the risks related to these tumors.
(1) thyroid follicular cell tumors may arise from long-term disturbances in thyroid-pituitary hormonal feedback under conditions of reduced circulating thyroid hormone and elevated thyroid stimulating hormone (TSH);
(2) the steps leading to these tumors are expected to show thresholds, such that the risks of tumor development are minimal when thyroid-pituitary homeostasis exists; and
(3) models that assume thresholds may be used to assess the risks of certain thyroid follicular cell tumors where there is evidence of thyroid-pituitary imbalance.
The policy set out in this report provides guidance on determining whether it is reasonable to presume that the observed thyroid follicular tumors are the result of thyroid-pituitary imbalance, and on selecting appropriate procedures to use in estimating the risks related to these tumors.
Additional Information
Note: a complete electronic version of this document that preserves its original appearance (such as in a pdf file format) is not currently available.